Drug intelligence / Profile preview

visnagin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Visnagin is a naturally occurring **furanochromone** compound extracted from the fruit of *Ammi visnaga* plant. It possesses a distinctive molecular structure characterized by a **chromone backbone fused with a furan ring**, with a methoxy group at the 5-position and a methyl group attached to the furan ring. The compound demonstrates **multiple pharmacological activities** including vasodilatory, anti-inflammatory, antioxidant, and cardioprotective properties. Its mechanism of action involves **modulation of mitochondrial enzymes**, particularly mitochondrial malate dehydrogenase, **inhibition of NF-κB and MAPK signaling pathways**, upregulation of Nrf2 (a key regulator of antioxidant defense mechanisms), and reduction of oxidative stress. Visnagin also exhibits **anti-apoptotic effects** and enhances autophagy in cardiac tissue. The compound has shown protective effects against doxorubicin-induced cardiotoxicity, cerulein-induced acute pancreatitis, ischemia/reperfusion injury, and inflammatory conditions. Additional biological activities include antispasmodic, antidiabetic potential, antimicrobial, cytotoxic effects on cancer cells, and immunostimulatory properties. The molecular formula is C13H10O4 with a molecular weight of 230.2.

Other names
4-methoxy-7-methylfuro[3,2-g]chromen-5-onevisnaginevisnagidindesmethoxykhellin4-methoxy-7-methyl-5H-furo(3,2-g)(1)-benzopyran-5-oneFUK-724FUK724FUK 724
02

Targets

MDH2 (Mitochondrial Malate Dehydrogenase)

Beyond the preview

Go deeper on visnagin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on visnagin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call